Published in Infect Dis Clin North Am on September 01, 2010
Trends of tuberculosis case notification and treatment outcomes in the Sidama Zone, southern Ethiopia: ten-year retrospective trend analysis in urban-rural settings. PLoS One (2014) 1.62
Increased tuberculosis burden due to demographic transition in Korea from 2001 to 2010. Tuberc Respir Dis (Seoul) (2013) 1.40
Clinical characteristics and outcomes of Mycobacterium tuberculosis disease in adult patients with hematological malignancies. BMC Infect Dis (2011) 0.95
Tuberculosis control strategies to reach the 2035 global targets in China: the role of changing demographics and reactivation disease. BMC Med (2015) 0.90
Aging leads to prolonged duration of inflammation-induced depression-like behavior caused by Bacillus Calmette-Guérin. Brain Behav Immun (2013) 0.89
Characteristics and treatment outcomes of tuberculosis cases by risk groups, Japan, 2007-2010. Western Pac Surveill Response J (2013) 0.87
The influence of ageing on the development and management of rheumatoid arthritis. Nat Rev Rheumatol (2013) 0.85
Prevalence and patterns of multimorbidity among tuberculosis patients in Brazil: a cross-sectional study. Int J Equity Health (2013) 0.85
Changes in tuberculin skin test positivity over 20 years in periurban shantytowns in Lima, Peru. Am J Trop Med Hyg (2013) 0.84
Microarray analysis of Mycobacterium tuberculosis-infected monocytes reveals IL26 as a new candidate gene for tuberculosis susceptibility. Immunology (2015) 0.82
Posterior only versus combined posterior and anterior approaches for lower lumbar tuberculous spondylitis with neurological deficits in the aged. Spinal Cord (2015) 0.81
Macrophages from elders are more permissive to intracellular multiplication of Mycobacterium tuberculosis. Age (Dordr) (2012) 0.81
Prevention of tuberculosis in older adults in the United States: obstacles and opportunities. Clin Infect Dis (2013) 0.79
Acid suppressive agents and risk of Mycobacterium tuberculosis: case-control study. BMC Gastroenterol (2014) 0.78
Genetically diverse mice are novel and valuable models of age-associated susceptibility to Mycobacterium tuberculosis. Immun Ageing (2014) 0.77
Cloning of the Recombinant Cytochrome P450 Cyp141 Protein of Mycobacterium tuberculosis as a Diagnostic Target and Vaccine Candidate. Iran Red Crescent Med J (2014) 0.77
Production and Purification of Mycolyl Transferase B of Mycobacterium tuberculosis. Tanaffos (2011) 0.76
Does non-central nervous system tuberculosis increase the risk of ischemic stroke? A population-based propensity score-matched follow-up study. PLoS One (2014) 0.76
Is population ageing cancelling out progress made in tuberculosis control in Hong Kong Special Administrative Region SAR (China)? Age-adjusted analysis of case notification data, 1990-2015. Western Pac Surveill Response J (2017) 0.75
Expression and Purification of the Recombinant Cytochrome P450 CYP141 Protein of Mycobacterium Tuberculosis as a Diagnostic Tool and Vaccine Production. Iran Red Crescent Med J (2015) 0.75
Microbiome Changes during Tuberculosis and Antituberculous Therapy. Clin Microbiol Rev (2016) 0.75
Multidrug resistant pulmonary tuberculosis treatment regimens and patient outcomes: an individual patient data meta-analysis of 9,153 patients. PLoS Med (2012) 4.69
Treatment outcomes of patients with multidrug-resistant and extensively drug-resistant tuberculosis according to drug susceptibility testing to first- and second-line drugs: an individual patient data meta-analysis. Clin Infect Dis (2014) 2.75
Comparative roles of levofloxacin and ofloxacin in the treatment of multidrug-resistant tuberculosis: preliminary results of a retrospective study from Hong Kong. Chest (2003) 1.65
Antituberculosis drugs and hepatotoxicity. Respirology (2006) 1.62
Lethal interaction: the colliding epidemics of tobacco and tuberculosis. Expert Rev Anti Infect Ther (2007) 1.41
Treatment of tuberculosis and optimal dosing schedules. Thorax (2010) 1.13
Management of multidrug-resistant tuberculosis: Update 2007. Respirology (2008) 1.01
Exposure to avian influenza H7N9 in farms and wet markets. Lancet (2013) 1.00
Household contact investigation of tuberculosis in low-income and middle-income countries: public-health impact. Lancet Infect Dis (2009) 0.96
Systematic review of interferon-gamma release assays in tuberculosis: focus on likelihood ratios. Thorax (2010) 0.95
Reexamining the role of radiography in tuberculosis case finding. Int J Tuberc Lung Dis (2011) 0.94
The association between symptoms and microbiologically defined response to tuberculosis treatment. Ann Am Thorac Soc (2013) 0.92
Genetic association between a chemokine gene CXCL-10 (IP-10, interferon gamma inducible protein 10) and susceptibility to tuberculosis. Clin Chim Acta (2009) 0.90
Association of polymorphisms in the Chr18q11.2 locus with tuberculosis in Chinese population. Hum Genet (2013) 0.90
Prognostic significance of early weight gain in underweight patients with tuberculosis. Am J Respir Crit Care Med (2006) 0.89
Further evidence for a link between silica dust and esophageal cancer. Int J Cancer (2005) 0.88
Update in tuberculosis 2008. Am J Respir Crit Care Med (2009) 0.84
Comparison of intracellular cytokine flow cytometry and an enzyme immunoassay for evaluation of cellular immune response to active tuberculosis. Clin Vaccine Immunol (2009) 0.83
Management of tuberculosis and latent tuberculosis infection in human immunodeficiency virus-infected persons. Respirology (2013) 0.83
Update in tuberculosis 2007. Am J Respir Crit Care Med (2008) 0.82
Transmission of multidrug-resistant and extensively drug-resistant tuberculosis in a metropolitan city. Eur Respir J (2012) 0.81
Update in tuberculosis 2005. Am J Respir Crit Care Med (2006) 0.80
Does metabolic syndrome cause obstructive sleep apnoea? Respir Med (2007) 0.79
Acetaminophen and asthma: spurious association? Am J Respir Crit Care Med (2011) 0.78
Corticosteroid administration and treatment failure in acute exacerbation of chronic obstructive pulmonary disease. JAMA (2010) 0.78
Year in review 2014: Lung cancer, pleural diseases, respiratory infections and tuberculosis, bronchoscopic intervention and imaging. Respirology (2015) 0.78
Diagnosing tuberculosis in patients with HIV: do we know enough? Am J Respir Crit Care Med (2009) 0.78
Nutrient supplementation and tuberculosis treatment outcome. J Infect Dis (2009) 0.77
Harnessing the full sterilising activity of rifamycins. Int J Tuberc Lung Dis (2011) 0.77
Treatment of tuberculosis in HIV-infected patients: we need to know more. Am J Respir Crit Care Med (2007) 0.77
The best approach to reintroducing tuberculosis treatment after hepatotoxicity is still open to debate. Clin Infect Dis (2010) 0.77
Smoking and tuberculosis: infection, disease, and mortality. Arch Intern Med (2007) 0.76
Update in tuberculosis 2006. Am J Respir Crit Care Med (2007) 0.76
Discordance in spirometric interpretations using different reference equations. Chest (2009) 0.75
Decline in prevalence of latent tuberculosis infection: is the waning of tuberculin reaction a factor? Am J Respir Crit Care Med (2008) 0.75
Acquired rifamycin mono-resistance and dosing schedules in HIV-related tuberculosis. Am J Respir Crit Care Med (2010) 0.75
Study on twins: a good tool for infectious diseases? Am J Respir Crit Care Med (2008) 0.75
Year in review 2011: respiratory infections, tuberculosis, pleural diseases, bronchoscopic intervention and imaging. Respirology (2012) 0.75
Empirical use of fluoroquinolones for chest infections may mask tuberculosis and jeopardise chances of survival. Int J Tuberc Lung Dis (2012) 0.75
Lung cancer is more common in early GOLD stages of COPD: a spurious association? Am J Respir Crit Care Med (2012) 0.75
Streptomycin susceptibility and MDR-TB: can we refine the definition of XDR-TB? Am J Respir Crit Care Med (2011) 0.75
Moxifloxacin versus ethambutol in initial tuberculosis treatment. Lancet (2009) 0.75
Can some patients with multidrug-resistant tuberculosis be cured with shorter duration of chemotherapy? Am J Respir Crit Care Med (2010) 0.75
Toward optimizing treatment for Mycobacterium avium complex lung disease. Am J Respir Crit Care Med (2007) 0.75
Is the whole-blood gamma interferon assay better than the tuberculin skin test in predicting active tuberculosis? Am J Respir Crit Care Med (2008) 0.75
Screening contacts of tuberculosis: overcoming obstacles with an old tool. Am J Respir Crit Care Med (2008) 0.75
Side effects of antituberculosis therapy. Am J Respir Crit Care Med (2004) 0.75
Does current drug resistance surveillance provide useful information in tuberculosis? Am J Respir Crit Care Med (2009) 0.75
HIV-related TB and adverse drug events. Thorax (2007) 0.75
Inhaled corticosteroids might not protect against lung cancer. Am J Respir Crit Care Med (2008) 0.75
How should we treat "difficult" multidrug-resistant tuberculosis? Chest (2009) 0.75
Can the interferon-gamma release assay help diagnose active tuberculosis in the elderly? Chest (2008) 0.75
Year in review 2012: lung cancer, respiratory infections, tuberculosis, pleural diseases, bronchoscopic intervention and imaging. Respirology (2013) 0.75
American Thoracic Society/European Respiratory Society 2005 standardization of DL measurement: impact on performance. Respirology (2008) 0.75